845 related articles for article (PubMed ID: 17030271)
81. Adenocarcinoma of the esophagogastric junction: a summary of responses to a questionnaire on adenocarcinoma of the esophagus and the esophagogastric junction in Japan.
Nakamura T; Ide H; Eguchi R; Ota M; Shimizu S; Isono K
Dis Esophagus; 2002; 15(3):219-25. PubMed ID: 12444994
[TBL] [Abstract][Full Text] [Related]
82. [Surgical resection in esophageal-gastric junction adenocarcinoma].
Bulat C; Stoian M; Damian M; Pricop A
Rev Med Chir Soc Med Nat Iasi; 2006; 110(1):122-7. PubMed ID: 19292090
[TBL] [Abstract][Full Text] [Related]
83. [Siewert-Stein classification of adenocarcinoma of the esophagogastric junction].
Szántó I; Vörös A; Gonda G; Nagy P; Altorjay A; Banai J; Gamal EM; Cserepes E
Magy Seb; 2001 Jun; 54(3):144-9. PubMed ID: 11432164
[TBL] [Abstract][Full Text] [Related]
84. Comparison of the 8th UICC staging system for esophageal and gastric cancers in Siewert type II junctional adenocarcinomas.
Karstens KF; Ghadban T; Sawez S; Konczalla L; Woestemeier A; Bachmann K; Uzunoglu FG; Tachezy M; Vettorazzi E; Izbicki JR; Reeh M
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):638-643. PubMed ID: 31879051
[TBL] [Abstract][Full Text] [Related]
85. [Surgical therapy for esophageal carcinoma: a prospective 20-year analysis].
Gockel I; Sultanov FS; Domeyer M; Trinh TT; Gönner U; Junginger T
Zentralbl Chir; 2008 Jun; 133(3):260-6. PubMed ID: 18563693
[TBL] [Abstract][Full Text] [Related]
86. Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial.
Veeramachaneni NK; Zoole JB; Decker PA; Putnam JB; Meyers BF;
Ann Thorac Surg; 2008 Aug; 86(2):418-21; discussion 421. PubMed ID: 18640307
[TBL] [Abstract][Full Text] [Related]
87. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
[TBL] [Abstract][Full Text] [Related]
88. Surgical management of the esogastric junction adenocarcinoma according to its histological types.
Ene D; Popescu S; Ciurea R; Oprea CD; Sfîrlează LM
Rom J Morphol Embryol; 2012; 53(1):95-8. PubMed ID: 22395506
[TBL] [Abstract][Full Text] [Related]
89. Laparoscopic en bloc lower mediastinal lymph node dissection via transhiatal approach for adenocarcinoma of esophagogastric junction.
Sakaguchi M; Hosogi H; Kanaya S
Surg Oncol; 2021 Mar; 36():34-35. PubMed ID: 33285434
[TBL] [Abstract][Full Text] [Related]
90. [Carcinomas of the esophago-gastric junction: surgical strategies].
Siegel G; Wagner M; Seiler Ch
Swiss Surg; 2003; 9(3):121-6. PubMed ID: 12815832
[TBL] [Abstract][Full Text] [Related]
91. [Understanding and controversy of the gastroesophageal junction adenocarcinoma].
Zhang XH; Wang QZ
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):947-9. PubMed ID: 19174001
[No Abstract] [Full Text] [Related]
92. Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection.
Schmidt T; Alldinger I; Blank S; Klose J; Springfeld C; Dreikhausen L; Weichert W; Grenacher L; Bruckner T; Lordick F; Ulrich A; Büchler MW; Ott K
Eur J Surg Oncol; 2015 Oct; 41(10):1340-7. PubMed ID: 26213358
[TBL] [Abstract][Full Text] [Related]
93. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
Haverkamp L; Seesing MF; Ruurda JP; Boone J; V Hillegersberg R
Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27001442
[TBL] [Abstract][Full Text] [Related]
94. [Current approaches to the surgical treatment of cancer of the cardioesophageal junction].
Chernousov AF; Kiladze MA
Khirurgiia (Mosk); 1995; (2):6-9. PubMed ID: 7616713
[TBL] [Abstract][Full Text] [Related]
95. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
[TBL] [Abstract][Full Text] [Related]
96. [Comparison of the effect of lymph node dissection performed by Ivor-Lewis or left-sided thoracic esophagogastrectomy for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
Duan XF; Gong L; Ma MQ; Yue J; Tang P; Shang XB; Jiang HJ; Yu ZT
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):190-194. PubMed ID: 28316217
[No Abstract] [Full Text] [Related]
97. Surgical management of and long-term survival after adenocarcinoma of the cardia.
Mariette C; Castel B; Toursel H; Fabre S; Balon JM; Triboulet JP
Br J Surg; 2002 Sep; 89(9):1156-63. PubMed ID: 12190682
[TBL] [Abstract][Full Text] [Related]
98. Surgical treatment of carcinoma of the gastric cardia.
Peracchia A; Bardini R; Asolati M; Ruol A; Bonavina L; Castoro C; Pavanello M
Hepatogastroenterology; 1991 Dec; 38 Suppl 1():72-5. PubMed ID: 1823069
[TBL] [Abstract][Full Text] [Related]
99. Staging of adenocarcinoma of the gastroesophageal junction.
Parry K; Haverkamp L; Bruijnen RC; Siersema PD; Offerhaus GJ; Ruurda JP; van Hillegersberg R
Eur J Surg Oncol; 2016 Mar; 42(3):400-6. PubMed ID: 26777127
[TBL] [Abstract][Full Text] [Related]
100. Thoracoabdominal gastrectomy and distal 2/3 esophageal resection with wide lymph node dissection for type II and III adenocarcinoma at the gastro-esophageal junction.
Jeremiasen M; Walther B; Djerf P; Staël von Holstein C; Zilling T; Hermansson M; Falkenback D; Johansson J
Am J Surg; 2019 Aug; 218(2):329-334. PubMed ID: 30635210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
